Sialic acid is an indicator of inflammation due to cardiopulmonary bypass but not myocardial damage

Journal of Cardiovascular Surgery

Volumn 43, Issue 4, 2002, Pages 489-493

  Berkan, O ^a   Gol M K ^a   Gunay I ^a   Sagaban M ^a  

^a CUMHURIYET UNIVERSITY   (Turkey)

Author keywords

Cardiopulmonary bypass; Inflammation, blood; Inflammation, etiology; N acetyleneuraminic acid, blood

Indexed keywords

ACUTE PHASE PROTEIN; BIOLOGICAL MARKER; CREATINE KINASE MB; FIBRINOGEN; LACTIC ACID; SIALIC ACID;

ADULT; AORTA CLAMPING; ARTERIAL BLOOD; ARTICLE; BLOOD LEVEL; CARDIOPLEGIA; CARDIOPULMONARY BYPASS; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY BYPASS GRAFT; CORONARY SINUS; CORRELATION ANALYSIS; ELECTIVE SURGERY; FEMALE; HEART ARREST; HEART MUSCLE INJURY; HEART MUSCLE ISCHEMIA; HUMAN; MALE; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; TIME;

ACUTE-PHASE PROTEINS; ACUTE-PHASE REACTION; CARDIOPULMONARY BYPASS; CASE-CONTROL STUDIES; CORONARY ARTERY BYPASS; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIUM; N-ACETYLNEURAMINIC ACID; PROSPECTIVE STUDIES; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; TIME FACTORS;

EID: 0036696437     PISSN: 00219509     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Ng S, Dain JA, Rosenburg A, Schengrund S, York J. The natural occurrence of sialic acids. In: Rosenberg V, Shengrund C, editors. Biological role of sialic acid. New York: Plenum; 1976.p.59-102.
2. Allain P, Olivier E, Le-Bouil A, Benoit C, Geslin P, Tadei A. Increase of sialic acid concentration in the plasma of patients with coronary disease. Presse Med 1996;25:96-8.
3. Watts GF, Crook MA, Haq S, Mandalia S. Serum sialic acid as a indicator of change in coronary disease. Metabolism 1995;44:147-8.
4. Crook JR, Goldman JH, Dalziel M, Madden B, Mc Kenna WJ. Increased ventricular sialylation in-patients with heart failure secondary to ischemic heart disease. Clin Cardiol 1997;20:455-8.
5. Hanson VA, Shettigar UR, Loungani RR, NadijCK-MBa MD. Plasma sialidase activity in acute myocardial infarction. Am Heart J 1987;14:59-63.
6. Hrncir Z, Pidrman V, Tichy M, Hamet A. Serum sialic acid in acute myocardial infarction in a dynamic follow-up. Vintr Leg 1975;21: 436-9.
7. Chu JS, Kishion S, Nomura A, Myazaki K. Serum α1-acid glycoprotein, sialic acid, and protein binding of disopyramide in normal subjects and cardiac patients. Chung Kuo Yao li Hsues Pao 1997;18:408-10.
8. Lindenberg G, Eklung, Gullberg B, Rastam L. Serum sialic acid concentration and cardiovascular mortality. BMJ 1991;302:143-6.
9. Mendall MA, Patel P, Ballam L, Strachan D, Nortfield TC. C reactive protein and its relation to cardiovascular risk factors. A population based cross sectional study. BMJ 1996;27(312):1061-5.
10. Taniuchi K, Chifu K, Hayashi N. A new enzymatic method for the determination of sialic acid in serum and its application for marker of acute phase reactants. Kobe J Med Sci 1981;27:91-102.
11. Hag M, Hag S, Tutt P, Crook M. Serum total sialic acid and lipid-associated sialic acid in normal individuals and patients with myocardial infarction, and their relationships to acute phase proteins. Ann Clin Biochem 1993;30:383-6.
12. Crook M, Hag M, Hag S, Tutt P. Plasma sialic acid and acute-phase proteins in patients with myocardial infarction. Angiology 1994;45:709-15.
13. Butler J, Rocker GM, Westaby S. Inflammatory response to cardiopulmonary bypass. Ann Thorac Surg 1993;55:552-9.
14. Petren S, Vesterberg O. The N-acetylneuraminic acid conent of five forms of human transferring. Biochem Biophys Acta 1989;994:161-5.
15. Abdelmouttaleb I, Danchin N, Ilardo C, Aimone Gastin I, Angioi M, Lozniewski A et al. C-reactive protein and coronary artery disease: additional evidence of the implication of an inflammatory process in acute coronary syndromes. Am Heart J 1999;137: 346-51.
16. Berendes E, Mollhoff T, Aken HV, Erren M, Deng MC, Loi CKHM. Increased plasma concentrations of serum amyloid A: an indicator of the acute-phase response after cardiopulmonary bypass. Crit Care Med 1997;25:1527-33.